Food & Beverages
Global Bioactive Protein and Peptides Market Research Report 2025
- Mar 13, 25
- ID: 130459
- Pages: 100
- Figures: 94
- Views: 12
The global market for Bioactive Protein and Peptides was valued at US$ 1924 million in the year 2024 and is projected to reach a revised size of US$ 3054 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Bioactive proteins and peptides are considered as important ingredients in functional foods, nutraceuticals and personal care. The roles of bioactive proteins and peptides include antioxidant, antimicrobial, antihypertensive, immunomodulatory and other biological activities.
Global key players of bioactive protein and peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, etc. The top five players hold a share over 50%. North America is the largest market, has a share about 40%, followed by Europe, and Asia-Pacific, with share 30% and 20%, separately.
This report aims to provide a comprehensive presentation of the global market for Bioactive Protein and Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioactive Protein and Peptides.
The Bioactive Protein and Peptides market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bioactive Protein and Peptides market comprehensively. Regional market sizes, concerning products by Source, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioactive Protein and Peptides companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Source, by Application, and by regions.
Market Segmentation
By Company
Gelita
Kerry Group
Vital Proteins
Rousselot
BRF Ingredients
Bunge Ltd
Ingredia Nutritional
Gelatines Weishardt
PanTheryx
Hubei Reborn Biotech
Seagarden
Shandong Hengxin Biotech
Baotou Dongbao Bio-Tech
Wuhan Jiushengtang Biotech
Morinaga Milk
Collagile
Nuritas
SmartPEP
Segment by Source
Plant Source
Animal Source
Segment by Application
Functional Food
Dietary Supplements
Personal Care
Animal Nutrition
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Source, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioactive Protein and Peptides company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Source, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Bioactive proteins and peptides are considered as important ingredients in functional foods, nutraceuticals and personal care. The roles of bioactive proteins and peptides include antioxidant, antimicrobial, antihypertensive, immunomodulatory and other biological activities.
Global key players of bioactive protein and peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, etc. The top five players hold a share over 50%. North America is the largest market, has a share about 40%, followed by Europe, and Asia-Pacific, with share 30% and 20%, separately.
This report aims to provide a comprehensive presentation of the global market for Bioactive Protein and Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioactive Protein and Peptides.
The Bioactive Protein and Peptides market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bioactive Protein and Peptides market comprehensively. Regional market sizes, concerning products by Source, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioactive Protein and Peptides companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Source, by Application, and by regions.
Market Segmentation
By Company
Gelita
Kerry Group
Vital Proteins
Rousselot
BRF Ingredients
Bunge Ltd
Ingredia Nutritional
Gelatines Weishardt
PanTheryx
Hubei Reborn Biotech
Seagarden
Shandong Hengxin Biotech
Baotou Dongbao Bio-Tech
Wuhan Jiushengtang Biotech
Morinaga Milk
Collagile
Nuritas
SmartPEP
Segment by Source
Plant Source
Animal Source
Segment by Application
Functional Food
Dietary Supplements
Personal Care
Animal Nutrition
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Source, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioactive Protein and Peptides company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Source, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Source
1.2.1 Global Bioactive Protein and Peptides Market Size Growth Rate by Source: 2020 VS 2024 VS 2031
1.2.2 Plant Source
1.2.3 Animal Source
1.3 Market by Application
1.3.1 Global Bioactive Protein and Peptides Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Functional Food
1.3.3 Dietary Supplements
1.3.4 Personal Care
1.3.5 Animal Nutrition
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioactive Protein and Peptides Market Perspective (2020-2031)
2.2 Global Bioactive Protein and Peptides Growth Trends by Region
2.2.1 Global Bioactive Protein and Peptides Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bioactive Protein and Peptides Historic Market Size by Region (2020-2025)
2.2.3 Bioactive Protein and Peptides Forecasted Market Size by Region (2026-2031)
2.3 Bioactive Protein and Peptides Market Dynamics
2.3.1 Bioactive Protein and Peptides Industry Trends
2.3.2 Bioactive Protein and Peptides Market Drivers
2.3.3 Bioactive Protein and Peptides Market Challenges
2.3.4 Bioactive Protein and Peptides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioactive Protein and Peptides Players by Revenue
3.1.1 Global Top Bioactive Protein and Peptides Players by Revenue (2020-2025)
3.1.2 Global Bioactive Protein and Peptides Revenue Market Share by Players (2020-2025)
3.2 Global Bioactive Protein and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bioactive Protein and Peptides Revenue
3.4 Global Bioactive Protein and Peptides Market Concentration Ratio
3.4.1 Global Bioactive Protein and Peptides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioactive Protein and Peptides Revenue in 2024
3.5 Global Key Players of Bioactive Protein and Peptides Head office and Area Served
3.6 Global Key Players of Bioactive Protein and Peptides, Product and Application
3.7 Global Key Players of Bioactive Protein and Peptides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioactive Protein and Peptides Breakdown Data by Source
4.1 Global Bioactive Protein and Peptides Historic Market Size by Source (2020-2025)
4.2 Global Bioactive Protein and Peptides Forecasted Market Size by Source (2026-2031)
5 Bioactive Protein and Peptides Breakdown Data by Application
5.1 Global Bioactive Protein and Peptides Historic Market Size by Application (2020-2025)
5.2 Global Bioactive Protein and Peptides Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bioactive Protein and Peptides Market Size (2020-2031)
6.2 North America Bioactive Protein and Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bioactive Protein and Peptides Market Size by Country (2020-2025)
6.4 North America Bioactive Protein and Peptides Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioactive Protein and Peptides Market Size (2020-2031)
7.2 Europe Bioactive Protein and Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bioactive Protein and Peptides Market Size by Country (2020-2025)
7.4 Europe Bioactive Protein and Peptides Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioactive Protein and Peptides Market Size (2020-2031)
8.2 Asia-Pacific Bioactive Protein and Peptides Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2020-2025)
8.4 Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioactive Protein and Peptides Market Size (2020-2031)
9.2 Latin America Bioactive Protein and Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bioactive Protein and Peptides Market Size by Country (2020-2025)
9.4 Latin America Bioactive Protein and Peptides Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioactive Protein and Peptides Market Size (2020-2031)
10.2 Middle East & Africa Bioactive Protein and Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2020-2025)
10.4 Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gelita
11.1.1 Gelita Company Details
11.1.2 Gelita Business Overview
11.1.3 Gelita Bioactive Protein and Peptides Introduction
11.1.4 Gelita Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.1.5 Gelita Recent Development
11.2 Kerry Group
11.2.1 Kerry Group Company Details
11.2.2 Kerry Group Business Overview
11.2.3 Kerry Group Bioactive Protein and Peptides Introduction
11.2.4 Kerry Group Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.2.5 Kerry Group Recent Development
11.3 Vital Proteins
11.3.1 Vital Proteins Company Details
11.3.2 Vital Proteins Business Overview
11.3.3 Vital Proteins Bioactive Protein and Peptides Introduction
11.3.4 Vital Proteins Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.3.5 Vital Proteins Recent Development
11.4 Rousselot
11.4.1 Rousselot Company Details
11.4.2 Rousselot Business Overview
11.4.3 Rousselot Bioactive Protein and Peptides Introduction
11.4.4 Rousselot Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.4.5 Rousselot Recent Development
11.5 BRF Ingredients
11.5.1 BRF Ingredients Company Details
11.5.2 BRF Ingredients Business Overview
11.5.3 BRF Ingredients Bioactive Protein and Peptides Introduction
11.5.4 BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.5.5 BRF Ingredients Recent Development
11.6 Bunge Ltd
11.6.1 Bunge Ltd Company Details
11.6.2 Bunge Ltd Business Overview
11.6.3 Bunge Ltd Bioactive Protein and Peptides Introduction
11.6.4 Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.6.5 Bunge Ltd Recent Development
11.7 Ingredia Nutritional
11.7.1 Ingredia Nutritional Company Details
11.7.2 Ingredia Nutritional Business Overview
11.7.3 Ingredia Nutritional Bioactive Protein and Peptides Introduction
11.7.4 Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.7.5 Ingredia Nutritional Recent Development
11.8 Gelatines Weishardt
11.8.1 Gelatines Weishardt Company Details
11.8.2 Gelatines Weishardt Business Overview
11.8.3 Gelatines Weishardt Bioactive Protein and Peptides Introduction
11.8.4 Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.8.5 Gelatines Weishardt Recent Development
11.9 PanTheryx
11.9.1 PanTheryx Company Details
11.9.2 PanTheryx Business Overview
11.9.3 PanTheryx Bioactive Protein and Peptides Introduction
11.9.4 PanTheryx Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.9.5 PanTheryx Recent Development
11.10 Hubei Reborn Biotech
11.10.1 Hubei Reborn Biotech Company Details
11.10.2 Hubei Reborn Biotech Business Overview
11.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Introduction
11.10.4 Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.10.5 Hubei Reborn Biotech Recent Development
11.11 Seagarden
11.11.1 Seagarden Company Details
11.11.2 Seagarden Business Overview
11.11.3 Seagarden Bioactive Protein and Peptides Introduction
11.11.4 Seagarden Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.11.5 Seagarden Recent Development
11.12 Shandong Hengxin Biotech
11.12.1 Shandong Hengxin Biotech Company Details
11.12.2 Shandong Hengxin Biotech Business Overview
11.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Introduction
11.12.4 Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.12.5 Shandong Hengxin Biotech Recent Development
11.13 Baotou Dongbao Bio-Tech
11.13.1 Baotou Dongbao Bio-Tech Company Details
11.13.2 Baotou Dongbao Bio-Tech Business Overview
11.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Introduction
11.13.4 Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.13.5 Baotou Dongbao Bio-Tech Recent Development
11.14 Wuhan Jiushengtang Biotech
11.14.1 Wuhan Jiushengtang Biotech Company Details
11.14.2 Wuhan Jiushengtang Biotech Business Overview
11.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Introduction
11.14.4 Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.14.5 Wuhan Jiushengtang Biotech Recent Development
11.15 Morinaga Milk
11.15.1 Morinaga Milk Company Details
11.15.2 Morinaga Milk Business Overview
11.15.3 Morinaga Milk Bioactive Protein and Peptides Introduction
11.15.4 Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.15.5 Morinaga Milk Recent Development
11.16 Collagile
11.16.1 Collagile Company Details
11.16.2 Collagile Business Overview
11.16.3 Collagile Bioactive Protein and Peptides Introduction
11.16.4 Collagile Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.16.5 Collagile Recent Development
11.17 Nuritas
11.17.1 Nuritas Company Details
11.17.2 Nuritas Business Overview
11.17.3 Nuritas Bioactive Protein and Peptides Introduction
11.17.4 Nuritas Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.17.5 Nuritas Recent Development
11.18 SmartPEP
11.18.1 SmartPEP Company Details
11.18.2 SmartPEP Business Overview
11.18.3 SmartPEP Bioactive Protein and Peptides Introduction
11.18.4 SmartPEP Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.18.5 SmartPEP Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Source
1.2.1 Global Bioactive Protein and Peptides Market Size Growth Rate by Source: 2020 VS 2024 VS 2031
1.2.2 Plant Source
1.2.3 Animal Source
1.3 Market by Application
1.3.1 Global Bioactive Protein and Peptides Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Functional Food
1.3.3 Dietary Supplements
1.3.4 Personal Care
1.3.5 Animal Nutrition
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioactive Protein and Peptides Market Perspective (2020-2031)
2.2 Global Bioactive Protein and Peptides Growth Trends by Region
2.2.1 Global Bioactive Protein and Peptides Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bioactive Protein and Peptides Historic Market Size by Region (2020-2025)
2.2.3 Bioactive Protein and Peptides Forecasted Market Size by Region (2026-2031)
2.3 Bioactive Protein and Peptides Market Dynamics
2.3.1 Bioactive Protein and Peptides Industry Trends
2.3.2 Bioactive Protein and Peptides Market Drivers
2.3.3 Bioactive Protein and Peptides Market Challenges
2.3.4 Bioactive Protein and Peptides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioactive Protein and Peptides Players by Revenue
3.1.1 Global Top Bioactive Protein and Peptides Players by Revenue (2020-2025)
3.1.2 Global Bioactive Protein and Peptides Revenue Market Share by Players (2020-2025)
3.2 Global Bioactive Protein and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bioactive Protein and Peptides Revenue
3.4 Global Bioactive Protein and Peptides Market Concentration Ratio
3.4.1 Global Bioactive Protein and Peptides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioactive Protein and Peptides Revenue in 2024
3.5 Global Key Players of Bioactive Protein and Peptides Head office and Area Served
3.6 Global Key Players of Bioactive Protein and Peptides, Product and Application
3.7 Global Key Players of Bioactive Protein and Peptides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioactive Protein and Peptides Breakdown Data by Source
4.1 Global Bioactive Protein and Peptides Historic Market Size by Source (2020-2025)
4.2 Global Bioactive Protein and Peptides Forecasted Market Size by Source (2026-2031)
5 Bioactive Protein and Peptides Breakdown Data by Application
5.1 Global Bioactive Protein and Peptides Historic Market Size by Application (2020-2025)
5.2 Global Bioactive Protein and Peptides Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bioactive Protein and Peptides Market Size (2020-2031)
6.2 North America Bioactive Protein and Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bioactive Protein and Peptides Market Size by Country (2020-2025)
6.4 North America Bioactive Protein and Peptides Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioactive Protein and Peptides Market Size (2020-2031)
7.2 Europe Bioactive Protein and Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bioactive Protein and Peptides Market Size by Country (2020-2025)
7.4 Europe Bioactive Protein and Peptides Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioactive Protein and Peptides Market Size (2020-2031)
8.2 Asia-Pacific Bioactive Protein and Peptides Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2020-2025)
8.4 Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioactive Protein and Peptides Market Size (2020-2031)
9.2 Latin America Bioactive Protein and Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bioactive Protein and Peptides Market Size by Country (2020-2025)
9.4 Latin America Bioactive Protein and Peptides Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioactive Protein and Peptides Market Size (2020-2031)
10.2 Middle East & Africa Bioactive Protein and Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2020-2025)
10.4 Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gelita
11.1.1 Gelita Company Details
11.1.2 Gelita Business Overview
11.1.3 Gelita Bioactive Protein and Peptides Introduction
11.1.4 Gelita Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.1.5 Gelita Recent Development
11.2 Kerry Group
11.2.1 Kerry Group Company Details
11.2.2 Kerry Group Business Overview
11.2.3 Kerry Group Bioactive Protein and Peptides Introduction
11.2.4 Kerry Group Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.2.5 Kerry Group Recent Development
11.3 Vital Proteins
11.3.1 Vital Proteins Company Details
11.3.2 Vital Proteins Business Overview
11.3.3 Vital Proteins Bioactive Protein and Peptides Introduction
11.3.4 Vital Proteins Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.3.5 Vital Proteins Recent Development
11.4 Rousselot
11.4.1 Rousselot Company Details
11.4.2 Rousselot Business Overview
11.4.3 Rousselot Bioactive Protein and Peptides Introduction
11.4.4 Rousselot Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.4.5 Rousselot Recent Development
11.5 BRF Ingredients
11.5.1 BRF Ingredients Company Details
11.5.2 BRF Ingredients Business Overview
11.5.3 BRF Ingredients Bioactive Protein and Peptides Introduction
11.5.4 BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.5.5 BRF Ingredients Recent Development
11.6 Bunge Ltd
11.6.1 Bunge Ltd Company Details
11.6.2 Bunge Ltd Business Overview
11.6.3 Bunge Ltd Bioactive Protein and Peptides Introduction
11.6.4 Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.6.5 Bunge Ltd Recent Development
11.7 Ingredia Nutritional
11.7.1 Ingredia Nutritional Company Details
11.7.2 Ingredia Nutritional Business Overview
11.7.3 Ingredia Nutritional Bioactive Protein and Peptides Introduction
11.7.4 Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.7.5 Ingredia Nutritional Recent Development
11.8 Gelatines Weishardt
11.8.1 Gelatines Weishardt Company Details
11.8.2 Gelatines Weishardt Business Overview
11.8.3 Gelatines Weishardt Bioactive Protein and Peptides Introduction
11.8.4 Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.8.5 Gelatines Weishardt Recent Development
11.9 PanTheryx
11.9.1 PanTheryx Company Details
11.9.2 PanTheryx Business Overview
11.9.3 PanTheryx Bioactive Protein and Peptides Introduction
11.9.4 PanTheryx Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.9.5 PanTheryx Recent Development
11.10 Hubei Reborn Biotech
11.10.1 Hubei Reborn Biotech Company Details
11.10.2 Hubei Reborn Biotech Business Overview
11.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Introduction
11.10.4 Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.10.5 Hubei Reborn Biotech Recent Development
11.11 Seagarden
11.11.1 Seagarden Company Details
11.11.2 Seagarden Business Overview
11.11.3 Seagarden Bioactive Protein and Peptides Introduction
11.11.4 Seagarden Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.11.5 Seagarden Recent Development
11.12 Shandong Hengxin Biotech
11.12.1 Shandong Hengxin Biotech Company Details
11.12.2 Shandong Hengxin Biotech Business Overview
11.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Introduction
11.12.4 Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.12.5 Shandong Hengxin Biotech Recent Development
11.13 Baotou Dongbao Bio-Tech
11.13.1 Baotou Dongbao Bio-Tech Company Details
11.13.2 Baotou Dongbao Bio-Tech Business Overview
11.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Introduction
11.13.4 Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.13.5 Baotou Dongbao Bio-Tech Recent Development
11.14 Wuhan Jiushengtang Biotech
11.14.1 Wuhan Jiushengtang Biotech Company Details
11.14.2 Wuhan Jiushengtang Biotech Business Overview
11.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Introduction
11.14.4 Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.14.5 Wuhan Jiushengtang Biotech Recent Development
11.15 Morinaga Milk
11.15.1 Morinaga Milk Company Details
11.15.2 Morinaga Milk Business Overview
11.15.3 Morinaga Milk Bioactive Protein and Peptides Introduction
11.15.4 Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.15.5 Morinaga Milk Recent Development
11.16 Collagile
11.16.1 Collagile Company Details
11.16.2 Collagile Business Overview
11.16.3 Collagile Bioactive Protein and Peptides Introduction
11.16.4 Collagile Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.16.5 Collagile Recent Development
11.17 Nuritas
11.17.1 Nuritas Company Details
11.17.2 Nuritas Business Overview
11.17.3 Nuritas Bioactive Protein and Peptides Introduction
11.17.4 Nuritas Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.17.5 Nuritas Recent Development
11.18 SmartPEP
11.18.1 SmartPEP Company Details
11.18.2 SmartPEP Business Overview
11.18.3 SmartPEP Bioactive Protein and Peptides Introduction
11.18.4 SmartPEP Revenue in Bioactive Protein and Peptides Business (2020-2025)
11.18.5 SmartPEP Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Bioactive Protein and Peptides Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Plant Source
Table 3. Key Players of Animal Source
Table 4. Global Bioactive Protein and Peptides Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Bioactive Protein and Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Bioactive Protein and Peptides Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Bioactive Protein and Peptides Market Share by Region (2020-2025)
Table 8. Global Bioactive Protein and Peptides Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Bioactive Protein and Peptides Market Share by Region (2026-2031)
Table 10. Bioactive Protein and Peptides Market Trends
Table 11. Bioactive Protein and Peptides Market Drivers
Table 12. Bioactive Protein and Peptides Market Challenges
Table 13. Bioactive Protein and Peptides Market Restraints
Table 14. Global Bioactive Protein and Peptides Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Bioactive Protein and Peptides Market Share by Players (2020-2025)
Table 16. Global Top Bioactive Protein and Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioactive Protein and Peptides as of 2024)
Table 17. Ranking of Global Top Bioactive Protein and Peptides Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Bioactive Protein and Peptides Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Bioactive Protein and Peptides, Headquarters and Area Served
Table 20. Global Key Players of Bioactive Protein and Peptides, Product and Application
Table 21. Global Key Players of Bioactive Protein and Peptides, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bioactive Protein and Peptides Market Size by Source (2020-2025) & (US$ Million)
Table 24. Global Bioactive Protein and Peptides Revenue Market Share by Source (2020-2025)
Table 25. Global Bioactive Protein and Peptides Forecasted Market Size by Source (2026-2031) & (US$ Million)
Table 26. Global Bioactive Protein and Peptides Revenue Market Share by Source (2026-2031)
Table 27. Global Bioactive Protein and Peptides Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Bioactive Protein and Peptides Revenue Market Share by Application (2020-2025)
Table 29. Global Bioactive Protein and Peptides Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Bioactive Protein and Peptides Revenue Market Share by Application (2026-2031)
Table 31. North America Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Bioactive Protein and Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Bioactive Protein and Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Bioactive Protein and Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Bioactive Protein and Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Bioactive Protein and Peptides Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Bioactive Protein and Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Bioactive Protein and Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 46. Gelita Company Details
Table 47. Gelita Business Overview
Table 48. Gelita Bioactive Protein and Peptides Product
Table 49. Gelita Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 50. Gelita Recent Development
Table 51. Kerry Group Company Details
Table 52. Kerry Group Business Overview
Table 53. Kerry Group Bioactive Protein and Peptides Product
Table 54. Kerry Group Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 55. Kerry Group Recent Development
Table 56. Vital Proteins Company Details
Table 57. Vital Proteins Business Overview
Table 58. Vital Proteins Bioactive Protein and Peptides Product
Table 59. Vital Proteins Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 60. Vital Proteins Recent Development
Table 61. Rousselot Company Details
Table 62. Rousselot Business Overview
Table 63. Rousselot Bioactive Protein and Peptides Product
Table 64. Rousselot Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 65. Rousselot Recent Development
Table 66. BRF Ingredients Company Details
Table 67. BRF Ingredients Business Overview
Table 68. BRF Ingredients Bioactive Protein and Peptides Product
Table 69. BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 70. BRF Ingredients Recent Development
Table 71. Bunge Ltd Company Details
Table 72. Bunge Ltd Business Overview
Table 73. Bunge Ltd Bioactive Protein and Peptides Product
Table 74. Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 75. Bunge Ltd Recent Development
Table 76. Ingredia Nutritional Company Details
Table 77. Ingredia Nutritional Business Overview
Table 78. Ingredia Nutritional Bioactive Protein and Peptides Product
Table 79. Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 80. Ingredia Nutritional Recent Development
Table 81. Gelatines Weishardt Company Details
Table 82. Gelatines Weishardt Business Overview
Table 83. Gelatines Weishardt Bioactive Protein and Peptides Product
Table 84. Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 85. Gelatines Weishardt Recent Development
Table 86. PanTheryx Company Details
Table 87. PanTheryx Business Overview
Table 88. PanTheryx Bioactive Protein and Peptides Product
Table 89. PanTheryx Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 90. PanTheryx Recent Development
Table 91. Hubei Reborn Biotech Company Details
Table 92. Hubei Reborn Biotech Business Overview
Table 93. Hubei Reborn Biotech Bioactive Protein and Peptides Product
Table 94. Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 95. Hubei Reborn Biotech Recent Development
Table 96. Seagarden Company Details
Table 97. Seagarden Business Overview
Table 98. Seagarden Bioactive Protein and Peptides Product
Table 99. Seagarden Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 100. Seagarden Recent Development
Table 101. Shandong Hengxin Biotech Company Details
Table 102. Shandong Hengxin Biotech Business Overview
Table 103. Shandong Hengxin Biotech Bioactive Protein and Peptides Product
Table 104. Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 105. Shandong Hengxin Biotech Recent Development
Table 106. Baotou Dongbao Bio-Tech Company Details
Table 107. Baotou Dongbao Bio-Tech Business Overview
Table 108. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Product
Table 109. Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 110. Baotou Dongbao Bio-Tech Recent Development
Table 111. Wuhan Jiushengtang Biotech Company Details
Table 112. Wuhan Jiushengtang Biotech Business Overview
Table 113. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Product
Table 114. Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 115. Wuhan Jiushengtang Biotech Recent Development
Table 116. Morinaga Milk Company Details
Table 117. Morinaga Milk Business Overview
Table 118. Morinaga Milk Bioactive Protein and Peptides Product
Table 119. Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 120. Morinaga Milk Recent Development
Table 121. Collagile Company Details
Table 122. Collagile Business Overview
Table 123. Collagile Bioactive Protein and Peptides Product
Table 124. Collagile Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 125. Collagile Recent Development
Table 126. Nuritas Company Details
Table 127. Nuritas Business Overview
Table 128. Nuritas Bioactive Protein and Peptides Product
Table 129. Nuritas Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 130. Nuritas Recent Development
Table 131. SmartPEP Company Details
Table 132. SmartPEP Business Overview
Table 133. SmartPEP Bioactive Protein and Peptides Product
Table 134. SmartPEP Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 135. SmartPEP Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Bioactive Protein and Peptides Picture
Figure 2. Global Bioactive Protein and Peptides Market Size Comparison by Source (2020-2031) & (US$ Million)
Figure 3. Global Bioactive Protein and Peptides Market Share by Source: 2024 VS 2031
Figure 4. Plant Source Features
Figure 5. Animal Source Features
Figure 6. Global Bioactive Protein and Peptides Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Bioactive Protein and Peptides Market Share by Application: 2024 VS 2031
Figure 8. Functional Food Case Studies
Figure 9. Dietary Supplements Case Studies
Figure 10. Personal Care Case Studies
Figure 11. Animal Nutrition Case Studies
Figure 12. Other Case Studies
Figure 13. Bioactive Protein and Peptides Report Years Considered
Figure 14. Global Bioactive Protein and Peptides Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Bioactive Protein and Peptides Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Bioactive Protein and Peptides Market Share by Region: 2024 VS 2031
Figure 17. Global Bioactive Protein and Peptides Market Share by Players in 2024
Figure 18. Global Top Bioactive Protein and Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioactive Protein and Peptides as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Bioactive Protein and Peptides Revenue in 2024
Figure 20. North America Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Bioactive Protein and Peptides Market Share by Country (2020-2031)
Figure 22. United States Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Bioactive Protein and Peptides Market Share by Country (2020-2031)
Figure 26. Germany Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Bioactive Protein and Peptides Market Share by Region (2020-2031)
Figure 34. China Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Bioactive Protein and Peptides Market Share by Country (2020-2031)
Figure 42. Mexico Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Bioactive Protein and Peptides Market Share by Country (2020-2031)
Figure 46. Turkey Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Gelita Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 50. Kerry Group Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 51. Vital Proteins Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 52. Rousselot Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 53. BRF Ingredients Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 54. Bunge Ltd Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 55. Ingredia Nutritional Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 56. Gelatines Weishardt Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 57. PanTheryx Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 58. Hubei Reborn Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 59. Seagarden Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 60. Shandong Hengxin Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 61. Baotou Dongbao Bio-Tech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 62. Wuhan Jiushengtang Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 63. Morinaga Milk Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 64. Collagile Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 65. Nuritas Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 66. SmartPEP Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Bioactive Protein and Peptides Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Plant Source
Table 3. Key Players of Animal Source
Table 4. Global Bioactive Protein and Peptides Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Bioactive Protein and Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Bioactive Protein and Peptides Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Bioactive Protein and Peptides Market Share by Region (2020-2025)
Table 8. Global Bioactive Protein and Peptides Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Bioactive Protein and Peptides Market Share by Region (2026-2031)
Table 10. Bioactive Protein and Peptides Market Trends
Table 11. Bioactive Protein and Peptides Market Drivers
Table 12. Bioactive Protein and Peptides Market Challenges
Table 13. Bioactive Protein and Peptides Market Restraints
Table 14. Global Bioactive Protein and Peptides Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Bioactive Protein and Peptides Market Share by Players (2020-2025)
Table 16. Global Top Bioactive Protein and Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioactive Protein and Peptides as of 2024)
Table 17. Ranking of Global Top Bioactive Protein and Peptides Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Bioactive Protein and Peptides Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Bioactive Protein and Peptides, Headquarters and Area Served
Table 20. Global Key Players of Bioactive Protein and Peptides, Product and Application
Table 21. Global Key Players of Bioactive Protein and Peptides, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bioactive Protein and Peptides Market Size by Source (2020-2025) & (US$ Million)
Table 24. Global Bioactive Protein and Peptides Revenue Market Share by Source (2020-2025)
Table 25. Global Bioactive Protein and Peptides Forecasted Market Size by Source (2026-2031) & (US$ Million)
Table 26. Global Bioactive Protein and Peptides Revenue Market Share by Source (2026-2031)
Table 27. Global Bioactive Protein and Peptides Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Bioactive Protein and Peptides Revenue Market Share by Application (2020-2025)
Table 29. Global Bioactive Protein and Peptides Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Bioactive Protein and Peptides Revenue Market Share by Application (2026-2031)
Table 31. North America Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Bioactive Protein and Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Bioactive Protein and Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Bioactive Protein and Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Bioactive Protein and Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Bioactive Protein and Peptides Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Bioactive Protein and Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Bioactive Protein and Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Bioactive Protein and Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 46. Gelita Company Details
Table 47. Gelita Business Overview
Table 48. Gelita Bioactive Protein and Peptides Product
Table 49. Gelita Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 50. Gelita Recent Development
Table 51. Kerry Group Company Details
Table 52. Kerry Group Business Overview
Table 53. Kerry Group Bioactive Protein and Peptides Product
Table 54. Kerry Group Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 55. Kerry Group Recent Development
Table 56. Vital Proteins Company Details
Table 57. Vital Proteins Business Overview
Table 58. Vital Proteins Bioactive Protein and Peptides Product
Table 59. Vital Proteins Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 60. Vital Proteins Recent Development
Table 61. Rousselot Company Details
Table 62. Rousselot Business Overview
Table 63. Rousselot Bioactive Protein and Peptides Product
Table 64. Rousselot Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 65. Rousselot Recent Development
Table 66. BRF Ingredients Company Details
Table 67. BRF Ingredients Business Overview
Table 68. BRF Ingredients Bioactive Protein and Peptides Product
Table 69. BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 70. BRF Ingredients Recent Development
Table 71. Bunge Ltd Company Details
Table 72. Bunge Ltd Business Overview
Table 73. Bunge Ltd Bioactive Protein and Peptides Product
Table 74. Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 75. Bunge Ltd Recent Development
Table 76. Ingredia Nutritional Company Details
Table 77. Ingredia Nutritional Business Overview
Table 78. Ingredia Nutritional Bioactive Protein and Peptides Product
Table 79. Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 80. Ingredia Nutritional Recent Development
Table 81. Gelatines Weishardt Company Details
Table 82. Gelatines Weishardt Business Overview
Table 83. Gelatines Weishardt Bioactive Protein and Peptides Product
Table 84. Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 85. Gelatines Weishardt Recent Development
Table 86. PanTheryx Company Details
Table 87. PanTheryx Business Overview
Table 88. PanTheryx Bioactive Protein and Peptides Product
Table 89. PanTheryx Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 90. PanTheryx Recent Development
Table 91. Hubei Reborn Biotech Company Details
Table 92. Hubei Reborn Biotech Business Overview
Table 93. Hubei Reborn Biotech Bioactive Protein and Peptides Product
Table 94. Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 95. Hubei Reborn Biotech Recent Development
Table 96. Seagarden Company Details
Table 97. Seagarden Business Overview
Table 98. Seagarden Bioactive Protein and Peptides Product
Table 99. Seagarden Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 100. Seagarden Recent Development
Table 101. Shandong Hengxin Biotech Company Details
Table 102. Shandong Hengxin Biotech Business Overview
Table 103. Shandong Hengxin Biotech Bioactive Protein and Peptides Product
Table 104. Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 105. Shandong Hengxin Biotech Recent Development
Table 106. Baotou Dongbao Bio-Tech Company Details
Table 107. Baotou Dongbao Bio-Tech Business Overview
Table 108. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Product
Table 109. Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 110. Baotou Dongbao Bio-Tech Recent Development
Table 111. Wuhan Jiushengtang Biotech Company Details
Table 112. Wuhan Jiushengtang Biotech Business Overview
Table 113. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Product
Table 114. Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 115. Wuhan Jiushengtang Biotech Recent Development
Table 116. Morinaga Milk Company Details
Table 117. Morinaga Milk Business Overview
Table 118. Morinaga Milk Bioactive Protein and Peptides Product
Table 119. Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 120. Morinaga Milk Recent Development
Table 121. Collagile Company Details
Table 122. Collagile Business Overview
Table 123. Collagile Bioactive Protein and Peptides Product
Table 124. Collagile Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 125. Collagile Recent Development
Table 126. Nuritas Company Details
Table 127. Nuritas Business Overview
Table 128. Nuritas Bioactive Protein and Peptides Product
Table 129. Nuritas Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 130. Nuritas Recent Development
Table 131. SmartPEP Company Details
Table 132. SmartPEP Business Overview
Table 133. SmartPEP Bioactive Protein and Peptides Product
Table 134. SmartPEP Revenue in Bioactive Protein and Peptides Business (2020-2025) & (US$ Million)
Table 135. SmartPEP Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Bioactive Protein and Peptides Picture
Figure 2. Global Bioactive Protein and Peptides Market Size Comparison by Source (2020-2031) & (US$ Million)
Figure 3. Global Bioactive Protein and Peptides Market Share by Source: 2024 VS 2031
Figure 4. Plant Source Features
Figure 5. Animal Source Features
Figure 6. Global Bioactive Protein and Peptides Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Bioactive Protein and Peptides Market Share by Application: 2024 VS 2031
Figure 8. Functional Food Case Studies
Figure 9. Dietary Supplements Case Studies
Figure 10. Personal Care Case Studies
Figure 11. Animal Nutrition Case Studies
Figure 12. Other Case Studies
Figure 13. Bioactive Protein and Peptides Report Years Considered
Figure 14. Global Bioactive Protein and Peptides Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Bioactive Protein and Peptides Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Bioactive Protein and Peptides Market Share by Region: 2024 VS 2031
Figure 17. Global Bioactive Protein and Peptides Market Share by Players in 2024
Figure 18. Global Top Bioactive Protein and Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioactive Protein and Peptides as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Bioactive Protein and Peptides Revenue in 2024
Figure 20. North America Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Bioactive Protein and Peptides Market Share by Country (2020-2031)
Figure 22. United States Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Bioactive Protein and Peptides Market Share by Country (2020-2031)
Figure 26. Germany Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Bioactive Protein and Peptides Market Share by Region (2020-2031)
Figure 34. China Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Bioactive Protein and Peptides Market Share by Country (2020-2031)
Figure 42. Mexico Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Bioactive Protein and Peptides Market Share by Country (2020-2031)
Figure 46. Turkey Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Bioactive Protein and Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Gelita Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 50. Kerry Group Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 51. Vital Proteins Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 52. Rousselot Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 53. BRF Ingredients Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 54. Bunge Ltd Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 55. Ingredia Nutritional Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 56. Gelatines Weishardt Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 57. PanTheryx Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 58. Hubei Reborn Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 59. Seagarden Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 60. Shandong Hengxin Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 61. Baotou Dongbao Bio-Tech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 62. Wuhan Jiushengtang Biotech Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 63. Morinaga Milk Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 64. Collagile Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 65. Nuritas Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 66. SmartPEP Revenue Growth Rate in Bioactive Protein and Peptides Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Brushless Finish Nailer Market Research Report 2025
May 05, 25
Global Reversible Pneumatic Drilling Machine Market Research Report 2025
May 05, 25
Global Direct Drive Linear Motor Stage Market Research Report 2025
May 05, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232